Provided by Tiger Trade Technology Pte. Ltd.

Summit Therapeutics PLC

17.17
-0.7800-4.35%
Post-market: 17.190.0200+0.12%18:41 EDT
Volume:6.18M
Turnover:105.72M
Market Cap:13.70B
PE:-15.36
High:17.64
Open:17.61
Low:16.80
Close:17.95
52wk High:29.23
52wk Low:12.07
Shares:797.75M
Float Shares:154.32M
Volume Ratio:0.95
T/O Rate:4.00%
Dividend:- -
Dividend Rate:- -
EPS(TTM):-1.1177
EPS(LYR):-1.4439
ROE:-192.50%
ROA:-101.61%
PB:21.74
PE(LYR):-11.89

Loading ...

Feb 25, 2021

Major Issues Report

8-K - Current report
Feb 16, 2021

Beneficial Ownership Change

SC 13G - Statement of acquisition of beneficial ownership by individuals
Jan 15, 2021

Correspondence

CORRESP [Cover] - Correspondence
Nov 25, 2020

Beneficial Ownership Change

SC 13D/A [Amend] - General statement of acquisition of beneficial ownership
Nov 24, 2020

Major Issues Report

8-K/A [Amend] - Current report
Nov 23, 2020

Major Issues Report

8-K - Current report
Nov 16, 2020

Major Issues Report

8-K - Current report
Nov 16, 2020

Quarterly Report

10-Q - Quarterly report [Sections 13 or 15(d)]
Nov 13, 2020

Major Issues Report

8-K - Current report
Nov 13, 2020

Major Issues Report

8-K - Current report
Nov 10, 2020

Beneficial Ownership Change

SC 13D/A [Amend] - General statement of acquisition of beneficial ownership
Nov 10, 2020

Beneficial Ownership Change

SC 13D/A [Amend] - General statement of acquisition of beneficial ownership
Nov 06, 2020

Major Issues Report

8-K - Current report
Oct 13, 2020

Correspondence

CORRESP [Cover] - Correspondence
Oct 07, 2020

Beneficial Ownership Change

SC 13D/A [Amend] - General statement of acquisition of beneficial ownership
Oct 05, 2020

Employee Stock Ownership

S-8 - Securities to be offered to employees in employee benefit plans
Oct 05, 2020

Employee Stock Ownership

S-8 POS - Securities to be offered to employees in employee benefit plans, post-effective amendments
Oct 05, 2020

Major Issues Report

8-K - Current report
Sep 29, 2020

Major Issues Report

8-K - Current report
Sep 29, 2020

Major Issues Report

8-K - Current report